Literature DB >> 12582030

Association between the Met326Ile polymorphism of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase and prostate cancer risk: a prospective study.

Aimée E Paradis1, Philip W Kantoff, Edward Giovannucci, Meir J Stampfer, Jing Ma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12582030

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  3 in total

1.  Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.

Authors:  Stella Koutros; Fredrick R Schumacher; Richard B Hayes; Jing Ma; Wen-Yi Huang; Demetrius Albanes; Federico Canzian; Stephen J Chanock; E David Crawford; W Ryan Diver; Heather Spencer Feigelson; Edward Giovanucci; Christopher A Haiman; Brian E Henderson; David J Hunter; Rudolf Kaaks; Laurence N Kolonel; Peter Kraft; Loïc Le Marchand; Elio Riboli; Afshan Siddiq; Mier J Stampfer; Daniel O Stram; Gilles Thomas; Ruth C Travis; Michael J Thun; Meredith Yeager; Sonja I Berndt
Journal:  Cancer Res       Date:  2010-03-02       Impact factor: 12.701

2.  No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk.

Authors:  K Fall; J R Stark; L A Mucci; J Chan; M J Stampfer; T Kurth; P G Febbo; P Kantoff; J Ma
Journal:  Prostate       Date:  2008-09-15       Impact factor: 4.104

3.  Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients.

Authors:  Francesca Morgese; Davide Soldato; Silvia Pagliaretta; Riccardo Giampieri; Donatella Brancorsini; Mariangela Torniai; Silvia Rinaldi; Agnese Savini; Azzurra Onofri; Marina Scarpelli; Rossana Berardi
Journal:  Oncotarget       Date:  2017-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.